Alyeska Investment Group
NBP

Alyeska Investment Group’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Alyeska Investment Group’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-151,520
Closed -$7.14M – 777
2020
Q4 		$7.14M Buy
+151,520
New +$5.97M 0.1% 234

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
WA
WFM Asia Road Town, Tortola, British Virgin Islands $632M AUM 14.51% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Alyeska Investment Group's NBP Position: Q1 2021 in Review

Alyeska Investment Group sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2021, closing a stake of 151,520 shares — an estimated $7.14M sold.

Alyeska Investment Group first reported a position in NBP in Q4 2020 and held it in 1 quarter. The position peaked at $7.14M in Q4 2020. 80 funds tracked by Wall St. Rank hold NBP as of Q1 2021.

  • Alyeska Investment Group reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 151,520 NovaBridge Biosciences American Depositary Shares shares in Q1 2021, an estimated $7.14M.
  • Alyeska Investment Group first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and held it in 1 quarter.
  • Alyeska Investment Group's NovaBridge Biosciences American Depositary Shares position peaked at $7.14M in Q4 2020.
  • 80 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2021.

Based on Alyeska Investment Group's 13F filing for Q1 2021, filed 17 May 2021.